Search Results

There are 7280 results for: content related to: Chronic activation of vasopressin V2 receptor signalling lowers renal medullary oxygen levels in rats

  1. Desmopressin use for minimising perioperative allogeneic blood transfusion

    Intervention Review

    The Cochrane Library

    Michael Desborough, Lise J Estcourt, Carolyn Doree, Marialena Trivella and Simon J Stanworth

    Published Online : 26 JAN 2004, DOI: 10.1002/14651858.CD001884.pub2

  2. You have free access to this content
    DDAVP IS NOT A PANACEA FOR CHILDREN WITH BLEEDING DISORDERS

    British Journal of Haematology

    Volume 108, Issue 2, February 2000, Pages: 217–227, Sutor

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.01814.x

  3. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype

    Haemophilia

    Volume 18, Issue 1, January 2012, Pages: 50–55, M. E. SEARY, D. FELDMAN and M. D. CARCAO

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1365-2516.2011.02572.x

  4. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane–aqueous system

    Biopolymers

    Volume 81, Issue 5, 5 April 2006, Pages: 321–338, Magdalena J. Ślusarz, Rafał Ślusarz and Jerzy Ciarkowski

    Version of Record online : 6 DEC 2005, DOI: 10.1002/bip.20420

  5. You have free access to this content
    Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus

    Acta Physiologica

    Volume 214, Issue 2, June 2015, Pages: 176–188, B. K. Kishore, N. G. Carlson, C. M. Ecelbarger, D. E. Kohan, C. E. Müller, R. D. Nelson, J. Peti-Peterdi and Y. Zhang

    Version of Record online : 4 MAY 2015, DOI: 10.1111/apha.12507

  6. You have free access to this content
    Vasopressin-stimulated CFTR Cl currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome

    The Journal of Physiology

    Volume 562, Issue 1, January 2005, Pages: 271–284, Chiz-Tzung Chang, Marcelle Bens, Edith Hummler, Sheerazed Boulkroun, Laurent Schild, Jacques Teulon, Bernard C. Rossier and Alain Vandewalle

    Version of Record online : 22 DEC 2004, DOI: 10.1113/jphysiol.2004.077933

  7. You have free access to this content
    Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 4, April 2003, Pages: 682–689, J. E. Kaufmann and U. M. Vischer

    Version of Record online : 21 MAR 2003, DOI: 10.1046/j.1538-7836.2003.00190.x

  8. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders

    Haemophilia

    Volume 14, Issue 3, May 2008, Pages: 524–530, F. L. HANEBUTT, N. ROLF, A. LOESEL, E. KUHLISCH, G. SIEGERT and R. KNOEFLER

    Version of Record online : 18 FEB 2008, DOI: 10.1111/j.1365-2516.2008.01672.x

  9. ACTH and cortisol release following intravenous desmopressin: a dose–response study

    Clinical Endocrinology

    Volume 51, Issue 5, November 1999, Pages: 653–658, Lucinda V. Scott, Sami Medbak and Timothy G. Dinan

    Version of Record online : 12 MAY 2003, DOI: 10.1046/j.1365-2265.1999.00850.x

  10. You have free access to this content
    A Systematic Review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy

    Haemophilia

    Volume 18, Issue 1, January 2012, Pages: 25–33, D. E. TRIGG, I. STERGIOTOU, P. PEITSIDIS and R. A. KADIR

    Version of Record online : 30 MAY 2011, DOI: 10.1111/j.1365-2516.2011.02573.x

  11. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease

    Haemophilia

    Volume 14, Issue 3, May 2008, Pages: 539–548, A. SHARTHKUMAR, A. GREIST, J. DI PAOLA, J. WINAY, C. ROBERSON, M. HEIMAN, S. HERBERT, R. PARAMESWARAN and A. SHAPIRO

    Version of Record online : 25 FEB 2008, DOI: 10.1111/j.1365-2516.2008.01666.x

  12. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007)

    Haemophilia

    Volume 14, Issue s1, January 2008, Pages: 5–14, A. B. FEDERICI

    Version of Record online : 21 DEC 2007, DOI: 10.1111/j.1365-2516.2007.01610.x

  13. You have free access to this content
    Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

    Haemophilia

    Volume 10, Issue 3, May 2004, Pages: 218–231, K. J. Pasi, P. W. Collins, D. M. Keeling, S. A. Brown, A. M. Cumming, G. C. Dolan, C. R. M. Hay, F. G. H. Hill, M. Laffan and I. R. Peake

    Version of Record online : 11 MAR 2004, DOI: 10.1111/j.1365-2516.2004.00886.x

  14. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 158–167, C. Leissinger, M. Carcao, J. C. Gill, J. Journeycake, T. Singleton and L. Valentino

    Version of Record online : 12 AUG 2013, DOI: 10.1111/hae.12254

  15. Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review

    Acta Physiologica

    Volume 213, Issue 1, January 2015, Pages: 107–144, G. J. Kemp, R. E. Ahmad, K. Nicolay and J. J. Prompers

    Version of Record online : 29 MAY 2014, DOI: 10.1111/apha.12307

  16. Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

    Haemophilia

    Volume 22, Issue 1, January 2016, Pages: 110–120, J. Windyga, G. Dolan, C. Altisent, O. Katsarou, M.-F. López Fernández, B. Zülfikar and on behalf of the EHTSB

    Version of Record online : 24 JUL 2015, DOI: 10.1111/hae.12763

  17. The nucleobase adenine as a signalling molecule in the kidney

    Acta Physiologica

    Volume 213, Issue 4, April 2015, Pages: 808–818, D. Thimm, A. C. Schiedel, J. Peti-Peterdi, B. K. Kishore and C. E. Müller

    Version of Record online : 28 JAN 2015, DOI: 10.1111/apha.12452

  18. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis

    Clinical Endocrinology

    Volume 49, Issue 6, December 1998, Pages: 793–801, J. M. Hunsballe, T. K. Hansen, S. Rittig, E. B. Pedersen and J. C. Djurhuus

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2265.1998.00587.x

  19. High-dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

    Haemophilia

    Volume 7, Issue 3, May 2001, Pages: 258–266, C. Leissinger, D. Becton, C. Cornell and J. Cox Gill

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2516.2001.00500.x

  20. Endothelial dysfunction and vascular disease – a 30th anniversary update

    Acta Physiologica

    P. M. Vanhoutte, H. Shimokawa, M. Feletou and E. H. C. Tang

    Version of Record online : 25 JAN 2016, DOI: 10.1111/apha.12646